Add-back therapy and gonadotropin-releasing hormone agonists in the treatment of patients with endometriosis: Can a consensus be reached?

Fertility and Sterility

Volumn 71, Issue 3, 1999, Pages 420-424

  Surrey, Eric S ^a,b  

^a Ctr for Repro Medicine and Surgery   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Add back therapy; Bone mineral density loss; Endometriosis; GnRH agonists

Indexed keywords

CONJUGATED ESTROGEN; ESTRADIOL; GONADORELIN AGONIST; MEDROXYPROGESTERONE ACETATE; NORETHISTERONE; NORETHISTERONE ACETATE;

ARTICLE; BONE DENSITY; CLINICAL PRACTICE; CLINICAL TRIAL; DRUG EFFECT; DRUG EFFICACY; ENDOMETRIOSIS; EVIDENCE BASED MEDICINE; FEMALE; HUMAN; LAPAROSCOPIC SURGERY; LIPID BLOOD LEVEL; PRIORITY JOURNAL; REMISSION; VASOMOTOR REFLEX;

BONE DENSITY; CLINICAL TRIALS; DIPHOSPHONATES; ENDOMETRIOSIS; ESTROGENS, CONJUGATED (USP); FEMALE; GONADOTROPIN-RELEASING HORMONE; HORMONES; HUMANS; MEDROXYPROGESTERONE; NORETHINDRONE;

EID: 0032964121     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(98)00500-7     Document Type: Article

References (17)

1. Dlugi A.M., Miller J.D., Knittle J. Lupron depot (leuprolide acetate for depot suspension) in the treatment of endometriosis a randomized placebo-controlled double blind study . Fertil Steril. 54:1990;419-427.
2. Henzl M.R., Corson S.L., Moghissi K., Buttram V.C., Berquist C., Jacobson J. Administration of nasal nafarelin as compared with oral danazol for endometriosis a randomized placebo-controlled, double-blind study . N Engl J Med. 318:1988;485-489.
3. Rock J.A., Truglia J.A., Caplan R.J. Zoladex (goserelin acetate implant) in the treatment of endometriosis a randomized comparison with danazol . Obstet Gynecol. 82:1993;198-205.
4. Surrey E.S. Steroidal and nonsteroidal "add-back" therapy extending safety and efficacy of gonadotropin-releasing hormone agonists in the gynecologic patient . Fertil Steril. 65:1995;673-685.
5. Gorguelo A., Hornstein M. The role of GnRH agonists plus add-back therapy in the treatment of endometriosis. Semin Reprod Endocrinol. 15:1997;273-284.
6. Hornstein M.D., Surrey E.S., Weisberg G.W., Casino L.A. Leuprolide acetate depot and hormonal add-back in endometriosis a 12-month study . Obstet Gynecol. 91:1998;16-24.
7. Edmonds D., Howell R. Can hormone replacement therapy be used during medical therapy of endometriosis? Br J Obstet Gynecol. 101:1994;24-26.
8. Moghissi K.S., Schlaff W.D., Olive D.L., Skinner M.A., Yin H. Goserelin acetate (Zoladex) with or without hormone replacement therapy for the treatment of endometriosis. Fertil Steril. 69:1998;1056-1062.
9. Kiiholma P., Korhonen M., Tuimala R., Korhonen M., Hagman E. Comparison of the gonadotropin-releasing hormone agonist goserelin acetate alone versus goserelin combined with estrogen-progestagen add-back therapy in the treatment of endometriosis. Fertil Steril. 64:1995;903-908.
10. Cedars M., Lu J., Meldrum D., Judd H. Treatment of endometriosis with a long-acting gonadotropin-releasing hormone agonist plus medroxyprogesterone acetate. Obstet Gynecol. 75:1990;641-645.
11. Makarainen L., Ronneberg L., Kauppila A. Medroxyprogesterone acetate supplementation diminishes the hypoestrogenic side-effects of gonadotropin-releasing hormone agonists without changing its efficacy in endometriosis. Fertil Steril. 65:1996;29-34.
12. Surrey E.S., Gambone J.C., Lu J.K.H., Judd H.L. The effects of combining norethindrone with a gonadotropin-releasing hormone agonist in the treatment of symptomatic endometriosis. Fertil Steril. 53:1990;620-626.
13. Riis B., Christiansen C., Johansen J., Jacobson J. Is it possible to prevent bone loss in young women treated with luteinizing hormone-releasing hormone agonists? J Clin Endocrinol Metab. 70:1990;920-924.
14. Surrey E., Judd H. Reduction of vasomotor symptoms and bone mineral density loss with combined norethindrone and long-acting gonadotropin-releasing hormone agonist therapy of symptomatic endometriosis a prospective randomized trial . J Clin Endocrinol Metab. 75:1992;558-563.
15. Tabkin O., Yakinoghe A.H., Kucuk S., Uryan I., Buhur A., Burak F. Effectiveness of tibolone on hypoestrogenic symptoms induced by goserelin treatment in patients with endometriosis. Fertil Steril. 67:1997;40-45.
16. Barbieri R. Hormone treatment of endometriosis the estrogen threshold hypothesis . Am J Obstet Gynecol. 166:1992;740-745.
17. Surrey E.S., Voigt B., Fournet N., Judd H.L. Prolonged gonadotropin-releasing hormone agonist treatment of symptomatic endometriosis the role of cyclic sodium etidronate and low dose norethindrone "add-back" therapy . Fertil Steril. 63:1995;747-755.